3,4-methylenedioxyamphetamine has been researched along with Anoxia, Brain in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bin, J | 1 |
| Wang, Q | 1 |
| Zhuo, YY | 1 |
| Xu, JP | 1 |
| Zhang, HT | 1 |
1 other study available for 3,4-methylenedioxyamphetamine and Anoxia, Brain
| Article | Year |
|---|---|
Piperphentonamine (PPTA) attenuated cerebral ischemia-induced memory deficits via neuroprotection associated with anti-apoptotic activity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Apoptosis; Avoidance Learning; Brain Ischemia; CA1 Region, H | 2012 |